2022 AASLD FOUNDATION DDW ABSTRACT AWARD RECIPIENTS
AASLD Foundation Abstract Awards recognize excellence and promote the professional development of early career investigators.
Congratulations to this year’s investigators who will present their award-winning abstracts at Digestive Disease Week® May 21-24, 2022.
AASLD Foundation Abstract Award in Healthcare Disparities Research
Aaron Yeoh, MD
Stanford University Hospital
Abstract Title: AMONG A NATIONAL COHORT OF U.S. VETERANS WITH METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE (MAFLD), HISPANICS AND AMERICAN INDIAN/ALASKA NATIVES HAVE SIGNIFICANTLY GREATER RISK OF CIRRHOSIS AT TIME OF MAFLD DIAGNOSIS
Mentor: Robert Wong, MD, MS
AASLD Foundation FELLOW Abstract Awards
Mrigya Babuta, PhD
Beth Israel Deaconess Medical Center and Harvard Medical School
Abstract Title: LIVER FIBROSIS IS ACCELERATED BY ALCOHOL BINGES IN MURINE NASH VIA NLRP3 INFLAMMASOME ACTIVATION, PYROPTOSIS AND NEUTROPHIL INFILTRATION
Mentor: Gyongyi Szabo, MD, PhD, FAASLD, AGAF, FACP
Adam Buckholz, MD
New York-Presbyterian and Weill Cornell Medical College
Abstract Title: ACCURATE PREDICTION MODELING OF SIX-WEEK MORTALITY AMONG PATIENTS WITH CIRRHOSIS PRESENTING WITH PORTAL HYPERTENSIVE BLEEDING: CALIBRATION AND EXTERNAL VALIDATION USING A MULTI-CENTER U.S. COHORT
Mentor: Brett Fortune, MD, MSc
Lixian Chen, PhD
Indiana University
Abstract Title: INHIBITION OF TRANSFORMING GROWTH FACTOR BETA 1 (TGFβ1) BY VIVO-MORPHOLINO (VM) AMELIORATES CHOLESTASIS IN THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
Mentor: Heather Francis, PhD
Souradipta Ganguly, PhD
University of California, San Diego
Abstract Title: FUNCTIONAL DEFECTS IN MACROPHAGES ACCELERATE NASH-HCC IN MICE LACKING TREM2
Mentor: David Brenner, MD; Debanjan Dhar, PhD
Cynthia Hsu, MD, PhD
University of California, San Diego
Abstract Title: INTESTINAL VIROME IN PATIENTS WITH ALCOHOL USE DISORDER AND AFTER ABSTINENCE
Mentor: Bernd Schnabl, MD
Garrett Kang, MBBS (NUS), MRCP (UK), MMED (NUS)
Changi General Hospital
Abstract Title: REAL-WORLD VALIDATION OF NON-INVASIVE PLATELET AND ELASTOGRAPHY CRITERIA TO PREDICT LIVER DECOMPENSATION IN COMPENSATED ADVANCED CHRONIC LIVER DISEASE PATIENTS - AN INTERNATIONAL STUDY
Mentor: Yu Jun Wong, FRCP (Edin), MMed (NUS), MD (UKM)
Hyunseok Kim, MD, MPH, PhD
Baylor College of Medicine
Abstract Title: PROGNOSIS AND CLINICAL CORRELATES OF OUTCOMES IN U.S. PATIENTS WITH INDETERMINATE PHASE CHRONIC HEPATITIS B VIRUS INFECTION
Mentor: Fasiha Kanwal, MD, MSHS
Cyriac Abby Philips MD, DM
The Liver Institute, Rajagiri Hospital, Kerala, India
Abstract Title: CLINICAL OUTCOMES AND GUT MICROBIOME CHANGES ASSOCIATED WITH HIGH DOSE PROBIOTIC INFUSION THERAPY IN PATIENTS WITH ALCOHOL-ASSOCIATED HEPATITIS – COMPARISONS WITH CORTICOSTEROIDS AND FECAL TRANSPLANTATION
Andy Tien, MD, MS
Kaiser Permanente Los Angeles Medical Center
Abstract Title: INCIDENCE AND OUTCOMES OF COVID-19 IN POST-LIVER TRANSPLANT RECIPIENTS AFTER COVID-19 VACCINATION IN A LARGE INTEGRATED HEALTHCARE SYSTEM
Mentor: Amandeep Sahota, MD, MS
Karn Wijarnpreecha, MD, MPH
University of Michigan
Abstract Title: HIGHER PREVALENCE OF CARDIOVASCULAR DISEASE AMONG LEAN VERSUS NON-LEAN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE DESPITE LOWER PREVALENCE OF ATHEROGENIC RISK AND METABOLIC DISEASES
Mentor: Anna S.F. Lok, MD
Alexander Yang, MD, MS and Bilal Asif, MD
University of Maryland and National Institutes of Health
Abstract Title: ALCOHOLIC STEATOSIS: IT’S ALL ABOUT THE LIPIDS
Mentor: Theo Heller, MD
Tianhao Zhou, PhD
Indiana University
Abstract Title: INHIBITION OF IL-33/ST2 SIGNALING REDUCES MAST CELL (MC)-INDUCED BILIARY DAMAGE AND PHENOTYPES OF PRIMARY SCLEROSING CHOLANGITIS (PSC) IN MDR2-/- MICE
Mentor: Heather Francis, PhD
Special Mentions
AASLD Foundation would like to additionally recognize the following investigator for excellence in hepatology research submitted to Digestive Disease Week who received the DDW Basic Science Travel Award.
Chaowapong Jarasvaraparn, MD
Washington University in St. Louis
Abstract Title: MACROPHAGE-RESTRICTED KNOCKOUT OF THE MITOCHONDRIAL PYRUVATE CARRIER REDUCES LIVER INFLAMMATION AND FIBROSIS IN A MOUSE MODEL OF NASH
Mentor: Brian Finck, PhD